Lance L. Engelmann
Monday, June 22, 2015
NOAC Antidote Promising in Phase III Trial
(MedPage Today) — Clotting normalized in most patients with serious bleeding or needing surgery.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment